Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

Director/PDMR Shareholding

29 Oct 2013 07:00

RNS Number : 5842R
W.H. Ireland Group PLC
29 October 2013
 



WH Ireland Group plc

 

("WH Ireland" or the "Company")

 

Director's dealing

 

WH Ireland announces that on 28 October 2013, Richard Killingbeck, Chief Executive Officer of the Company, and the WH Ireland Group plc Employee Share Ownership Trust ("ESOT") entered into a joint share ownership agreement ("JSOA") in relation to 1,000,000 ordinary shares of 5p each in the Company ("JSOA Shares").

 

Under the terms of the JSOA, Richard Killingbeck has an option to acquire the ESOT's interest in the JSOA Shares at a maximum price of ÂŁ0.745 per Share (the "Exercise Price") at any time between 28 October 2016 and 28 October 2023. The Exercise Price is subject to a formula based on a total return to WH Ireland shareholders over a 3 year period. It is dependent on the mid-market price of an ordinary share of 5p in the Company (an "Ordinary Share") on 28 October 2016 together with the aggregate dividends paid on an Ordinary Share over the preceding 3 year period (the "3 Year Value"). The main terms of the formula are that, in the event that the 3 Year Value is:

 

· less than or equal to £1.15, the Exercise Price will be £0.745

· £2.00 or more, the Exercise Price will be nil; and

· between £1.15 and £2.00 the Exercise Price will decrease on a sliding scale from £0.745 to nil.

 

This arrangement replaces a binding commitment that WH Ireland entered into with Mr Killingbeck prior to his appointment as Chief Executive Officer of the Company, entitling him to be granted an option over 473,787 Ordinary Shares, the terms of which were contained in an announcement made by the Company on 12 November 2012.

 

Following entering into the JSOA, Mr. Killingbeck will hold the following interests in the share capital of the Company:

 

Number of Shares

Percentage of voting rights

Nature of holding

805,000

3.40%

Beneficial

1,000,000

n/a

Held jointly with the ESOT

19,565

n/a

SAYE Scheme*

 

* Under the WH Ireland Save As You Earn Scheme (SAYE), assuming Mr Killingbeck continues to contribute at the full amount defined in his savings contract, this is the maximum number of Ordinary Shares that Mr Killingbeck will have an option to acquire under the terms of the SAYE.

 

For further information please contact:

WH Ireland Group plc

+44 (0) 20 7220 1666

Rupert Lowe, Chairman

Richard Killingbeck, CEO

Panmure Gordon (UK) Limited

+44 (0)20 7886 2500

Hugh Morgan (Corporate Finance)

Adam Pollock (Corporate Broking)

Abchurch Communications

+44 (0)20 7398 7718

Harriet Rae/Joanne Shears/Julian Bosdet

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFSAISLTFIV
Date   Source Headline
29th Nov 20217:00 amRNSNotice of Half Year Results
9th Nov 202110:41 amRNSESOT Purchases
26th Oct 20217:00 amRNSESOT Purchases
8th Oct 20217:00 amRNSAppointment of New Chief Financial Officer
21st Sep 20217:00 amRNSDirector Appointment
9th Sep 20217:58 amRNSEmployee Share Plan and PDMR Dealings
9th Sep 20217:00 amRNSESOT Purchases
12th Aug 20216:20 pmRNSResult of AGM
5th Aug 20213:50 pmRNSESOT Purchases
4th Aug 202110:23 amRNSPDMR and PCA shareholdings
26th Jul 20218:54 amRNSIssue of Equity and Total Voting Rights
20th Jul 20217:00 amRNSESOT Purchases
15th Jul 20217:00 amRNSFinal Results and Notice of AGM
5th Jul 20217:00 amRNSUpdate on Final Results
28th Jun 20217:00 amRNSHolding(s) in Company
21st Jun 20217:00 amRNSBoard Change
17th Jun 20217:00 amRNSESOT Purchases
20th May 20217:00 amRNSPDMR and PCA shareholdings
18th May 20217:00 amRNSEmployee Share Option Trust Purchase Plan
4th May 20217:01 amRNSBoard Changes & Participation in NED Share Scheme
4th May 20217:00 amRNSYear End Trading Update
17th Mar 202111:56 amRNSPDMR Dealing
11th Mar 20217:00 amRNSGrant of Options and Issue of Equity
15th Feb 20217:00 amRNSAppointment of NOMAD and Joint Broker
23rd Dec 202011:29 amRNSHolding(s) in Company
23rd Dec 20207:00 amRNSCompletion of Acquisition
22nd Dec 202011:48 amRNSHolding(s) in Company
18th Dec 202010:24 amRNSResult of General Meeting and Total Voting Rights
30th Nov 202010:47 amRNSResult of Placing and Notice of General Meeting
30th Nov 20207:00 amRNSConditional Acquisition & Placing for up to £5.3m
17th Nov 20207:00 amRNSNew Appointment
26th Oct 20207:00 amRNSInterim Results
24th Aug 20207:00 amRNSUpdate on Isle of Man Office
6th Aug 20203:02 pmRNSDirectorate Change
4th Aug 202011:39 amRNSResult of AGM
28th Jul 20201:00 pmRNSAdditional participation in NED Scheme
27th Jul 202012:50 pmRNSHolding(s) in Company
27th Jul 20207:00 amRNSPDMR shareholding
24th Jul 20203:22 pmRNSPDMR shareholding
23rd Jul 20201:40 pmRNSNew Remuneration Policy, Issue of Options & Equity
9th Jul 20207:00 amRNSFinal Results and Notice of AGM
2nd Jul 20207:00 amRNSDirectorate Change
29th Jun 20207:00 amRNSUpdate on Isle of Man Office
20th May 20207:00 amRNSBoard Changes
14th May 20203:47 pmRNSGeneral Update re Discussions
20th Apr 20207:00 amRNSResponse to Press Speculation
2nd Apr 20207:00 amRNSYear End Trading Update
27th Jan 20209:59 amRNSHolding(s) in Company
2nd Jan 20201:57 pmRNSHolding(s) in Company
31st Dec 201912:31 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.